Doxylamine succinate

CAS No. 562-10-7

Doxylamine succinate( NSC 74772 )

Catalog No. M15045 CAS No. 562-10-7

Doxylamine succinate competitively inhibits histamine at H1 receptors with substantial sedative and anticholinergic effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 45 In Stock
100MG 55 In Stock
200MG 92 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Doxylamine succinate
  • Note
    Research use only, not for human use.
  • Brief Description
    Doxylamine succinate competitively inhibits histamine at H1 receptors with substantial sedative and anticholinergic effects.
  • Description
    Doxylamine succinate competitively inhibits histamine at H1 receptors with substantial sedative and anticholinergic effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC 74772
  • Pathway
    GPCR/G Protein
  • Target
    Histamine Receptor
  • Recptor
    H1 receptor
  • Research Area
    Inflammation/Immunology
  • Indication
    ——

Chemical Information

  • CAS Number
    562-10-7
  • Formula Weight
    388.46
  • Molecular Formula
    C21H28N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 78 mg/mL (200.79 mM); Water: 78 mg/mL (200.79 mM); DMSO: 78 mg/mL (200.79 mM)
  • SMILES
    CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O
  • Chemical Name
    butanedioic acid;N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Bookstaff RC, et al. Toxicol Appl Pharmacol, 1996, 141(2), 584-594.
molnova catalog
related products
  • Metiamide

    Metiamide is a histamine H2-receptor antagonist .

  • Tecastemizole

    Tecastemizole is a selective antagonist of H1 receptor and a major metabolite of astemizole with anti-inflammatory effects.

  • Vapitadine

    Vapitadine is a non-sedative antihistamine compound that relieves itching caused by atopic dermatitis.